Symphony - 5/29 - short week, 1 day less.
Total 10749 vs previous week of 12202 which was a full week
My calcs are indicating a range of $3.20-$3.30 per share (have to guesstimate Europe, Japan, and VA) and based on that Fair Value would be $132-$140 based on Cash Flow, using a 12% cash flow discount ratio.
Analyst expectations are in the $2.60-$2.70 range.
ha ha, thanks for that ... always good to get a little breathe of fresh bear (although it can be a little smelly). unfortunately your post does not answer my question, which is: 'including the warrants and convertibles, how many shares are outstanding'.
I am with you on the HZNP/DEPO desire. Thanks for the heads up for FOLD, was in it awhile back for a trade and will kick it's tyres again
with respect to the SLXP takeover, SLXP traded below the VRX bid until the ENDP bid came along ... but the options told a very different story. Similar to what is going on here. Patience ....
First of all Celgene is a great company and i am sure many of the people at Receptos would be happy transitioning over. The fit is pretty interesting, it brings this part of the business into the line of fire of Biogen, and it would not surprise me one bit of Biogen raises the stakes just to force Celgene to pay market price (because we all know Celgene will pay more, the question is how much more). Kind of like what ENDP did to VRX during the Salix takeover drama which in effect forced VRX to pay closer to market value (which i was lucky to participate in after buying SLXP in November after the ignominious earnings call).
July 27, 2015: Gilead Sciences, Inc. (Nasdaq:GILD) today announced the promotion of William Lee, PhD to Executive Vice President, Research, and Brett Pletcher to Executive Vice President and General Counsel. Dr. Lee and Mr. Pletcher will both join Gilead’s senior leadership committee
the July 17th $295 traded almost 1100 contracts, the $290 traded 874 contracts .... and the $270 430 contracts.
interesting to say the least.
NEA distributed the shares to their partners who then went on a selling spree on Tuesday morning at the open ... and possibly towards the close today. i like SUPN, looking for a good entry which is around these levels now.
Doing some DD here, assuming SGYP received a $1.5 Billion offer, does that mean the value per share is just under $9 for the 'fully diluted outstanding' shares and warrants' ?
Congrats, but note that bulls make money, pigs get slaughtered ... so an experienced player would sell at least 50% here. but who am I, this is an anonymous message board and I could be a short (which I am not).
that was technically important this morning to hold the support at 22. hopefully we now go higher. Darn shorts are still in control.
I have played a lot of buyouts over the last 2 years (SNTS, TSRX, CADX, ITMN, SLXP, PCYC ) and have been handsomely rewarded. This is the first 'hostile' play I have been involved with, and this will take time to unfold. DEPO is clearly in play and management will try to convince shareholders and their BOD to not sell, but I can tell you a sell is coming - unfortunately, this was so undervalued it was screaming for a bid. Hang in, don't panic as games start being played (articles, messages on the board). we should see a price north of $30 ... hopefully $33-35. Best of luck to the longs.